MIF Antagonists (Carolus Therapeutics)

N/A

Report date: 2025/01/26 17:18:05

Base Information

Drug NameMIF Antagonists (Carolus Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionMacrophage migration inhibitory factor inhibitors
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarolus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarolus Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A